news

Apr 29 2013
Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering

Apr 18 2013
Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors

Apr 16 2013
KemPharm Advances KP201 Clinical and Commercial Program with Completion of Tablet Registration Activities